Healthcare & Life Sciences
Immunitas TX
United Stateswww.immunitastx.com
Immunitas TX is a Healthcare & Life Sciences startup based in the United States, most recent round Series B.
Activeseries-b
series-b
Stage
About Immunitas TX
Immunitas TX is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
Immunitas TX develops antibody-based immunotherapies targeting the CD161 receptor to treat cancer and autoimmune diseases, with clinical and preclinical programs including a lead cancer immunotherapy IMT-009 and a licensed autoimmune therapeutic.
Explore Immunitas TX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.